Pharvaris NV
NASDAQ:PHVS
Pharvaris NV
NASDAQ:PHVS
Price:
25.89
USD
-2.34%
Market Closed
Market Cap:
$1.7B
Pharvaris NV
Other
Last
Value
3 Years
3Y
CAGR
5 Years
5Y
CAGR
10 Years
10Y
CAGR
|
See Also
Pharvaris NV
Other Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Pharvaris NV
NASDAQ:PHVS
|
Other
€592k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
No Stocks Found
Pharvaris NV
Glance View
Pharvaris NV is a clinical-stage biopharmaceutical company. The company is headquartered in Leiden, Zuid-Holland and currently employs 34 full-time employees. The activity of the Company focuses on producing oral bradykinin B2-receptor antagonists and is advancing new alternatives to injected therapies for all sub-types of hereditary angioedema (HAE).
PHVS Intrinsic Value
HIDDEN
See Also
What is Pharvaris NV's Other?
Other
592k
EUR
592k
EUR
Based on the financial report for Dec 31, 2024, Pharvaris NV's Other amounts to 592k EUR.
